{"id":"https://openalex.org/W2065582486","doi":"https://doi.org/10.1016/0091-3057(86)90228-5","title":"Effects of calcium antagonists on phencyclidine behaviors","display_name":"Effects of calcium antagonists on phencyclidine behaviors","publication_year":1986,"publication_date":"1986-07-01","ids":{"openalex":"https://openalex.org/W2065582486","doi":"https://doi.org/10.1016/0091-3057(86)90228-5","mag":"2065582486","pmid":"https://pubmed.ncbi.nlm.nih.gov/3749237"},"language":"en","primary_location":{"id":"doi:10.1016/0091-3057(86)90228-5","doi":"https://doi.org/10.1016/0091-3057(86)90228-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0091-3057(86)90228-5","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030002656","display_name":"Gordon T. Bolger","orcid":"https://orcid.org/0000-0003-0971-5064","observed_orcids":["https://orcid.org/0000-0003-0971-5064"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.T. Bolger","raw_affiliation_strings":["Laboratory of Bioorgnic Chemistry, Bldg. 4, Room 212, NIADDK National Institutes of Health, Bethesda, MD 20205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Bioorgnic Chemistry, Bldg. 4, Room 212, NIADDK National Institutes of Health, Bethesda, MD 20205, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039818306","display_name":"Michael F. Rafferty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.F. Rafferty","raw_affiliation_strings":["Laboratory of Chemistry NIADDK, National Institutes of Health, Bethesda, MD 20205 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Chemistry NIADDK, National Institutes of Health, Bethesda, MD 20205 USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063501456","display_name":"Jacqueline N. Crawley","orcid":"https://orcid.org/0000-0002-1224-995X","observed_orcids":["https://orcid.org/0000-0002-1224-995X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.N. Crawley","raw_affiliation_strings":["Clinical Neurosciences Branch, NIMH, National Institutes of Health, Bethesda, MD 20205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neurosciences Branch, NIMH, National Institutes of Health, Bethesda, MD 20205, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101815684","display_name":"Steven M. Paul","orcid":"https://orcid.org/0009-0009-2773-8025","observed_orcids":["https://orcid.org/0009-0009-2773-8025","https://orcid.org/0000-0002-8388-2023"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.M. Paul","raw_affiliation_strings":["Clinical Neurosciences Branch, NIMH, National Institutes of Health, Bethesda, MD 20205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neurosciences Branch, NIMH, National Institutes of Health, Bethesda, MD 20205, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034829199","display_name":"Phil Skolnick","orcid":"https://orcid.org/0000-0002-2646-815X","observed_orcids":["https://orcid.org/0000-0002-2646-815X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Skolnick","raw_affiliation_strings":["Laboratory of Bioorgnic Chemistry, Bldg. 4, Room 212, NIADDK National Institutes of Health, Bethesda, MD 20205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Bioorgnic Chemistry, Bldg. 4, Room 212, NIADDK National Institutes of Health, Bethesda, MD 20205, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":null,"fwci":4.2632,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.93959732,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"1","first_page":"45","last_page":"49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.18490000069141388,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.07419999688863754,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.7950000166893005},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.8889999985694885},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.9549999833106995},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":1.0},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.7929999828338623},{"id":"https://openalex.org/keywords/dihydropyridine-binding-sites","display_name":"dihydropyridine binding sites","score":0.796999990940094},{"id":"https://openalex.org/keywords/rotarod-performance","display_name":"rotarod performance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/motor-activity","display_name":"motor activity","score":0.9079999923706055},{"id":"https://openalex.org/keywords/rearing-behavior","display_name":"rearing behavior","score":0.8629999756813049},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.5360000133514404},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.46000000834465027},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.9673848152160645},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.8434766530990601},{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.7869791984558105},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6326674222946167},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6308945417404175},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4874255955219269},{"id":"https://openalex.org/C2781212610","wikidata":"https://www.wikidata.org/wiki/Q39094","display_name":"Dihydropyridine","level":3,"score":0.4520088732242584},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.43199437856674194},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2980723977088928},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2910202145576477},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.18658322095870972},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13651695847511292}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004095","descriptor_name":"Dihydropyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009048","descriptor_name":"Motor Skills","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0091-3057(86)90228-5","doi":"https://doi.org/10.1016/0091-3057(86)90228-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0091-3057(86)90228-5","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},{"id":"pmid:3749237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3749237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology, biochemistry, and behavior","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W115306969","https://openalex.org/W592223485","https://openalex.org/W1527069372","https://openalex.org/W1836994250","https://openalex.org/W1908071549","https://openalex.org/W1964951153","https://openalex.org/W1968307837","https://openalex.org/W1975679961","https://openalex.org/W1976103658","https://openalex.org/W1976846700","https://openalex.org/W1977776516","https://openalex.org/W1982149522","https://openalex.org/W1989849146","https://openalex.org/W1992188204","https://openalex.org/W1993028270","https://openalex.org/W2008605357","https://openalex.org/W2010976666","https://openalex.org/W2020635303","https://openalex.org/W2026733207","https://openalex.org/W2027029852","https://openalex.org/W2037283960","https://openalex.org/W2039331111","https://openalex.org/W2039994072","https://openalex.org/W2042859126","https://openalex.org/W2042971065","https://openalex.org/W2047100613","https://openalex.org/W2049907486","https://openalex.org/W2059721218","https://openalex.org/W2061056399","https://openalex.org/W2061853389","https://openalex.org/W2062296106","https://openalex.org/W2066035525","https://openalex.org/W2070182120","https://openalex.org/W2076942439","https://openalex.org/W2079629736","https://openalex.org/W2084125212","https://openalex.org/W2084536694","https://openalex.org/W2086046018","https://openalex.org/W2173520866","https://openalex.org/W2249564079","https://openalex.org/W2401723718","https://openalex.org/W2406600646","https://openalex.org/W2410759084","https://openalex.org/W2410960818","https://openalex.org/W2412661964","https://openalex.org/W2421039408","https://openalex.org/W6671883239","https://openalex.org/W6691576128"],"related_works":["https://openalex.org/W2020913153","https://openalex.org/W2074206440","https://openalex.org/W1984809096","https://openalex.org/W2026184161","https://openalex.org/W1978759282","https://openalex.org/W2082830894","https://openalex.org/W2072191748","https://openalex.org/W2049790783","https://openalex.org/W2160116852","https://openalex.org/W2086046018"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}